Skip to content
Free previewYou are reading 1 of 33 lessons, in the same interface members use. Everything else unlocks with full access.Get full access · $150

1.1.1 - GxP Data Integrity and Regulatory Scope

GxP data integrity and regulatory scope

Foundational practice | Course scope date: November 1, 2026

A trustworthy regulated record allows an authorized reviewer to reconstruct what happened, who did it, when it happened, and how the reported result was obtained. This lesson establishes how to identify the applicable recordkeeping framework before choosing controls.

What you will learn

  • GxP foundations: record trustworthiness. Distinguish data integrity from data quality, information security, governance, records management, and good documentation practices.
  • Regulatory responsibilities: applicability. Map manufacturing, laboratory, nonclinical, clinical, distribution, and safety records to the activity and applicable requirements.
  • Regulatory responsibilities: equipment and records. Connect equipment controls with authorized changes, input/output verification, batch records, and complete laboratory records.
  • Regulatory responsibilities: independent review. Identify what a second-person laboratory review must establish beyond confirming a passing result.
  • Regulatory responsibilities: preservation. Select record-specific retention and inspection-availability controls without assuming one universal retention period.
Estimated time
25-35 minutes, including knowledge checks.
Blueprint mapping
GxP foundations and regulatory scope → GxP requirements and regulatory responsibilities → data integrity, applicable frameworks, and accountable recordkeeping. Blueprint objective: bp.d1.t1. Topic weight is not specified.
Prerequisites
None.
Key outputs
You should be able to choose a complete record over an unsupported summary, an applicable requirement over a familiar but irrelevant framework, and a justified retention decision over a blanket deletion rule.
WHY

Why it matters

  • A plausible result can still be unsuitable for a regulated decision when its origin, changes, or supporting data cannot be reconstructed.
  • Equipment maintenance, independent review, and record preservation address different weaknesses; success in one does not establish that the others are adequate.
  • Paper, hybrid, and electronic workflows all require trustworthy records, while additional electronic-record requirements depend on applicability.
  • The supplied course blueprint is scoped to November 1, 2026. Its references distinguish FDA requirements from international reference frameworks; it does not establish that every framework applies to every organization.
Where things stand: This lesson uses the FDA recordkeeping requirements identified in the course blueprint and treats PIC/S, MHRA, ICH, and European Commission EudraLex materials as international reference frameworks. Their exact editions and local applicability are not specified here. Confirm the applicable version and regulatory setting before using a framework to justify a local compliance decision.
KEY TERMS

Key Terms & Must-Know Facts

GxP
A collective term for good-practice frameworks applied to regulated activities; the relevant practice depends on the work being performed.
Data integrity
The trustworthiness of data throughout their lifecycle, including accuracy, completeness, consistency, attribution, reliability, and reconstructability.
Data quality
The suitability of data for their intended use; quality and integrity overlap, but a plausible or useful value alone does not establish its history.
ALCOA+
Attributable, legible, contemporaneous, original, and accurate, plus complete, consistent, enduring, and available.
Information security
Controls that protect information and systems, including appropriate access and protection against unauthorized alteration or loss.
Data governance
The allocation of accountability, decision rights, oversight, and expectations for data across the organization.
Records management
The organized identification, maintenance, retrieval, retention, and authorized disposition of records.
Good documentation practices
Practices for making clear, timely, attributable entries and controlled corrections while preserving the meaning and history of the record.
Raw data
Original observations and records, or appropriately verified copies where permitted, needed to reconstruct and evaluate the activity.
Metadata
Context that explains data, such as identity, time, units, method version, sequence, and relationships between records.
Predicate rule
An underlying FDA requirement that specifies records or other regulated obligations, independently of additional Part 11 requirements.
Retention trigger
The event from which an applicable retention period is calculated; the trigger must be identified along with the duration.

Must-know facts

  1. Part 11 does not automatically apply to every electronic file, application, or device.
  2. Part 11 controls, where applicable, operate alongside underlying recordkeeping requirements.
  3. For applicable finished-pharmaceutical manufacturing, equipment controls include written programs and appropriate verification, not simply possession of an instrument certificate.
  4. Required laboratory records include complete test data, methods, calculations, results, and identification of the people performing and reviewing the work.
  5. The required second-person laboratory review addresses accuracy, completeness, and compliance with established standards.
  6. Retention depends on the activity, record type, applicable requirement, and relevant trigger; inspection availability remains a separate operational obligation.
CORE

Core content

1.1.1.1 1. Trustworthiness versus a plausible result

A Explanation

Decision conflict: Should a reviewer accept a believable final result, or first establish that the supporting record is trustworthy? Choose the complete, attributable evidence needed for the decision. A numerical result can be correct while the record supporting it is incomplete.

WHY THIS IS TESTED: Professionals often encounter reassuring signals, such as an expected result, a signature, or a protected file, that answer only part of the integrity question.

Use ALCOA+ as a set of connected questions. Can you identify the responsible person? Read the record? Establish when the observation occurred? Locate the original evidence or an appropriate verified copy? Confirm the result? Follow the full sequence? Retrieve the record throughout its required life? A weakness in one dimension may prevent reconstruction even when the other dimensions appear satisfactory.

Reconstruction does not mean collecting every possible file. It means retaining the evidence necessary to explain the regulated activity and its decisions, including relevant context and changes. The required record may consist of linked paper and electronic components. See Fig 1.

Table 1. Related disciplines and their distinguishing questions
DisciplinePrimary questionWhat success alone does not establish
Data integrityCan the activity and result be trusted and reconstructed?That the underlying scientific method is suitable for every intended use.
Data qualityAre the data suitable for the intended purpose?That an apparently useful value has a complete, preserved history.
Information securityIs access and protection appropriate?That authorized users recorded all required observations.
Data governanceWho owns decisions, oversight, and accountability?That a specific record contains the required evidence.
Records managementCan records be located, retained, and appropriately disposed of?That every retained record was accurate when created.
Good documentation practicesWere entries and corrections made appropriately?That the complete electronic or hybrid record has been preserved.
Fig 1. Plausibility and reconstructability are separate checks
Exam takeaway: An acceptable-looking result still needs a trustworthy supporting record.
flowchart TD; A[Reported result] --> B{Result meets stated criteria?}; B -->|No| C[Use the applicable discrepancy process]; B -->|Yes| D{Supporting record reconstructable?}; D -->|No| E[Resolve the evidence gap before relying on the result]; D -->|Yes| F[Continue the required review];
A passing summary and its supporting record
Exam takeaway: A final summary must remain connected to the evidence needed to explain it.
{"prompt":"Square educational illustration for GxP professionals, white background, cool blue and gray with amber accents, clean semi-flat style. A QC analyst compares a short paper result marked Pass with a monitor displaying an original electronic test record, an acquisition sequence, operator identity, and a change-history panel. Use simple generic data with no real identifiers. The paper has visibly fewer fields than the electronic record. Include concise labels Summary and Supporting record. Do not imply that every printout is inadequate. Keep all text and objects inside a 6 percent white margin. No agency seals, decorative objects, gradients, or figure numbers.","caption":"A passing summary and its supporting record","size":"1024x1024"}
A reconstruction check
Exam takeaway: Start with the regulated decision and work back to its supporting evidence.
1. Identify the decision

Name what the record is being used to support.

2. Locate the source

Find the original observations and relevant linked records.

3. Establish context

Check identity, time, method, units, and sequence as applicable.

4. Follow changes

Determine whether corrections and their reasons remain understandable.

5. Test reconstruction

Ask whether an authorized reviewer can explain how the result was reached.

B Worked example

Scenario: A clinical data coordinator reviews records for a fictional 62-year-old participant with type 2 diabetes and chronic kidney disease. A routine hemoglobin result is 12.1 g/dL. A signed visit summary describes the participant as stable. The original observation was corrected, but the supplied export omits the earlier entry, the author of the correction, and its timing. The coordinator is asked to accept the export because the final value agrees with the summary.

  1. Identify the task: Determine whether the record supports reconstruction, not whether the participant's condition is clinically stable.
  2. Extract key facts: The export omits information about a correction. The age, comorbidities, and hemoglobin result do not resolve that omission.
  3. Apply the rule: Relevant changes and their attribution must remain understandable within the applicable record system.
  4. Eliminate alternatives: Agreement between two final values does not recover the missing history; obtaining another signature would not recreate it.
  5. Verify: Retrieve the linked source record and available change history, determine whether the correction can be explained, and document any unresolved gap through the established process.

Most appropriate next step: Obtain and review the supporting record before accepting the export as sufficient evidence. Missing information in an export does not, by itself, prove that the original system lost it.

C Exam trap

Common wrong answer: Accept an unsigned worksheet because it was kept in a locked cabinet. Why it is tempting: Physical protection makes alteration seem unlikely. Single eliminating clue: The person responsible for the entries cannot be identified; protection does not establish attribution.

D Checkpoint MCQ

A laboratory preserves every file in a protected repository, but sample identifiers cannot be linked to the corresponding acquisition records. Which conclusion is best supported?

  1. A. Integrity is established because the files are protected against deletion.
  2. B. Integrity is established because the record set appears complete by file count.
  3. C. Integrity remains unresolved because the relationships needed for reconstruction are missing.
  4. D. Integrity is established once a manager signs the repository inventory.

Answer: C.

  • A: Protection is reassuring, but preventing deletion does not establish which acquisition belongs to which sample.
  • B: A complete count suggests preservation, but it does not demonstrate that the records can be interpreted together.
  • C: This correctly focuses on missing contextual relationships, which prevent reconstruction despite the apparent availability of all files.
  • D: Managerial review provides accountability for the inventory, but a signature cannot replace missing sample-to-record links.
If you missed this: Review Trustworthiness versus a plausible result - focus on the difference between retaining files and reconstructing an activity.

1.1.1.2 2. Binding requirements versus reference guidance

A Explanation

Decision conflict: Should you apply the most familiar framework to every record, or first identify the activity, jurisdiction, and regulatory purpose? Begin with applicability. The same organization may operate manufacturing, clinical, and safety-reporting processes with different record obligations.

WHY THIS IS TESTED: Recognizing a regulation's name is insufficient if the learner applies it to the wrong activity or treats a reference framework as a universal legal rule.

Where rules and standards fit: The supplied blueprint identifies FDA regulations governing particular activities. Guidance and international frameworks help interpret expectations and design controls, but their authority and applicability must be assessed in context. A local procedure translates applicable obligations into assigned tasks; it cannot remove an applicable regulatory requirement. Conversely, a detailed local preference should not automatically be described as a universal FDA mandate.

For electronic records, assess the underlying recordkeeping obligation and how the electronic record is used. Part 11 applicability is a record-purpose assessment, not a label attached permanently to all software. Where applicable, its electronic-record and electronic-signature controls operate alongside predicate rules. FDA enforcement-discretion policies do not erase those underlying obligations. See Fig 2.

Table 2. Activity-to-record scope map
EnvironmentTypical record focusScope decision
Good manufacturing practice: manufacturing and pharmaceutical QCBatch production and control records, complete laboratory data, equipment and processing records.Determine the applicable manufacturing requirements; Part 211 is the specific FDA framework supplied for finished pharmaceuticals.
Good laboratory practice: applicable nonclinical studiesRaw observations, study documentation, controlled changes, reports, and archives.Determine whether the study falls within the applicable GLP framework; being performed in a laboratory alone does not establish GLP scope.
Good clinical practice: clinical investigationsAccurate case histories, supporting documentation, consent evidence, and investigational drug disposition.Identify the investigator's applicable responsibilities, including the supplied IND recordkeeping framework where relevant.
Good distribution practiceRecords supporting product movement, custody, and relevant storage conditions.Confirm the applicable distribution framework; the source scope does not supply jurisdiction-specific distribution requirements.
PharmacovigilanceSource case information, documented assessment, reporting history, and retained supporting records.Preserve case traceability across the lifecycle; detailed reporting deadlines and regional PV rules are outside this lesson's supplied scope.

Terminology boundary: GDP can mean good distribution practice or good documentation practices. Spell out the intended meaning before interpreting a policy or assigning a control.

Fig 2. Start electronic-record scope with the underlying obligation
Exam takeaway: The presence of software alone does not establish Part 11 applicability.
flowchart TD; A[Identify activity and record purpose] --> B{Underlying FDA record obligation identified?}; B -->|Unclear| C[Clarify the applicable record requirement]; B -->|Yes| D{Electronic record or signature used?}; D -->|Yes| E[Assess Part 11 scope and applicable controls]; D -->|No| F[Apply relevant paper record requirements]; E --> G[Retain predicate rule controls]; F --> G;
Regulation, guidance, and local procedure
Exam takeaway: Determine the authority and applicability of a document before using it to justify a control.
{"prompt":"Square professional education illustration, clean semi-flat blue and gray palette with one amber accent on white. A QA professional compares three separate generic documents on a desk labeled Regulation, Guidance, and Local procedure. Beside the documents is a small task card labeled Activity and record purpose. Show the professional thoughtfully comparing documents without a simple ranking arrow or claim that guidance is always optional. No official logos, seals, statutory quotations, legal advice, or figure numbers. Keep all text and objects within a 6 percent white margin.","caption":"Regulation, guidance, and local procedure","size":"1024x1024"}
A scope assessment sequence
Exam takeaway: Establish applicability before selecting the detailed control set.
1. Describe the activity

Identify manufacturing, testing, nonclinical, clinical, distribution, or safety work.

2. Name the record

State what obligation or decision it supports.

3. Identify the framework

Separate applicable requirements from supporting references.

4. Assess the format

Determine paper, electronic, and hybrid components and relevant electronic controls.

5. Assign accountability

Document the responsible role and route unresolved scope questions appropriately.

B Worked example

Scenario: A research site uses one platform for an actual investigational drug disposition log and a demonstration log used only with fictional training data. An actual participant is 48 years old with asthma and hypertension; potassium is 4.0 mmol/L. The platform vendor advertises a Part 11-ready package. A coordinator proposes applying the same regulatory classification to every file because both logs use that software.

  1. Identify the task: Classify the records by purpose and determine the appropriate applicability assessment.
  2. Extract key facts: One log documents actual drug disposition; the other contains fictional practice entries. The participant's medical details do not determine the software's regulatory scope.
  3. Apply the rule: Begin with the required record and its regulated use, then assess electronic-record requirements.
  4. Eliminate alternatives: A vendor claim does not decide organizational applicability, and a shared application does not make every file equivalent.
  5. Verify: Confirm that the demonstration log has no actual regulated recordkeeping use, identify the real disposition record's obligations, and document the control assessment with the accountable owner.

Most appropriate next step: Perform a record-purpose assessment for each use. The training label would not be enough if the supposedly fictional log were actually being relied on to document regulated work.

C Exam trap

Common wrong answer: Classify all pharmaceutical QC testing as nonclinical GLP work. Why it is tempting: Both activities occur in laboratories and generate scientific data. Single eliminating clue: The stated activity is finished-product release testing under applicable manufacturing requirements.

D Checkpoint MCQ

A company must decide whether an electronic worksheet falls within Part 11's scope. Which information should it establish first?

  1. A. Whether the software supplier markets a compliant edition.
  2. B. Whether the worksheet is used to satisfy an applicable FDA recordkeeping requirement.
  3. C. Whether the worksheet contains formulas or only text entries.
  4. D. Whether the worksheet is stored locally or on a company server.

Answer: B.

  • A: Supplier claims may inform later evaluation, but they cannot establish the company's regulated use of the worksheet.
  • B: This correctly identifies the record's regulatory purpose, which is the starting point for the applicability assessment.
  • C: Formulas can affect risk and control design, but a text-only electronic record may still have a regulated purpose.
  • D: Storage location affects implementation and protection, but it does not independently decide whether the record is in scope.
If you missed this: Review Binding requirements versus reference guidance - focus on regulated record purpose before software features.
Quick Recall:
  • A protected file with an unknown author satisfies which missing principle? None; attribution remains unresolved.
  • True or false: All work performed in a laboratory is GLP work. False; the activity and applicable framework determine scope.
  • Before applying Part 11, identify the underlying ______. Recordkeeping obligation and regulated use.

1.1.1.3 3. Equipment controls, complete records, and independent review

A Explanation

Decision conflict: Does an acceptable equipment status or final result justify record approval? Choose a review that evaluates both the controlled process and the complete evidence. Reject the assumption that calibration, a passing value, or a signature can stand in for the other required controls.

WHY THIS IS TESTED: Equipment suitability, authorized processing, record completeness, and independent review are connected but distinct responsibilities.

For applicable finished-pharmaceutical operations, the supplied Part 211 framework identifies written programs for calibration, inspection, and checks of automatic, mechanical, and electronic equipment. Computer-related controls must restrict relevant record changes to authorized personnel and provide appropriate verification of inputs and outputs. A calibrated instrument does not establish that subsequent transcription, calculations, processing, or changes were controlled. The appropriate extent of verification depends on the system and activity; this foundational lesson does not prescribe a vendor configuration or a universal verification frequency.

Keep batch and laboratory records connected without treating them as interchangeable. A batch record documents production and control activity. A laboratory record preserves the complete evidence derived from testing. A final certificate or summary can communicate the result, but it does not automatically contain everything required to reconstruct the test. See Fig 3.

Table 3. Distinct CGMP evidence requirements
Control areaEvidence to examineInadequate substitute
Equipment and computerized processing: 21 CFR 211.68(a)-(b)Applicable written programs, equipment check records, authorized change controls, and appropriate input/output verification.A current calibration label offered as proof that all data processing was controlled.
Batch production and control records: 21 CFR 211.188Required records of production and control activity for the batch, with the necessary connections to supporting evidence.A release summary that cannot be traced to the relevant batch activities.
Laboratory control records: 21 CFR 211.194Complete test data, methods, calculations, results, and identification of performing and reviewing personnel.A passing value with missing method, calculation, or original test evidence.
Second-person laboratory review: 21 CFR 211.194(a)(8)Review for accuracy, completeness, and compliance with established standards, documented by the second person.A countersignature based only on whether the reported result meets its limit.
Unexplained discrepancies and specification failures: 21 CFR 211.192Appropriate investigation and documentation under the established quality process.Replacing an unexplained result with a satisfactory repeat without addressing the discrepancy.

Review procedure: Establish that the relevant source data and context are available; compare the performed work with the applicable method and established standards; verify calculations and transferred values as appropriate; confirm who performed and reviewed the work; and resolve or escalate discrepancies through the authorized process. Do not document a review conclusion that the available evidence cannot support. See Fig 4.

Fig 3. Equipment assurance and record assurance must converge
Exam takeaway: A satisfactory equipment check does not replace verification of the resulting record.
flowchart TD; A[Applicable laboratory activity] --> B[Equipment checks and written program]; A --> C[Authorized processing and input output verification]; B --> D[Evidence of controlled operation]; C --> E[Evidence of controlled data handling]; D --> F[Complete laboratory record and independent review]; E --> F;
Fig 4. Review evidence before documenting approval
Exam takeaway: A second-person review must address more than the reported pass or fail status.
flowchart TD; A[Laboratory record presented for review] --> B{Required supporting evidence available?}; B -->|No| C[Obtain evidence and assess the gap]; B -->|Yes| D[Review accuracy completeness and compliance]; D --> E{Unresolved discrepancy?}; E -->|Yes| F[Use the established investigation process]; E -->|No| G[Document the supported review conclusion];
From equipment status to controlled processing
Exam takeaway: Check the path from instrument operation to the recorded output.
{"prompt":"Square educational scene in a pharmaceutical QC laboratory. A reviewer compares an instrument maintenance log with a computerized worksheet showing an input field, a calculation field, and an output field. Show a small equipment status label and a separate change authorization record so they are clearly different evidence sources. The workstation contains only generic fictional data. Clean semi-flat blue and gray style, white background, restrained amber accents, thin crisp outlines. Short labels Equipment checks and Data handling. No invented numerical limits, no regulatory seals, no figure numbers, and a 6 percent white outer margin.","caption":"From equipment status to controlled processing","size":"1024x1024"}
Independent laboratory review
Exam takeaway: The second reviewer examines supporting work rather than merely adding another signature.
{"prompt":"Square clean educational illustration of two distinct pharmaceutical laboratory professionals at adjacent work areas. One analyst performs a test and records an observation; a second reviewer examines the original electronic record, a method document, and a calculation worksheet. Use concise labels Analyst and Second reviewer. The second reviewer is visibly checking evidence rather than only stamping a final result. Blue and gray semi-flat style with one amber accent, white background, minimal shading, no personal identifiers, no agency logos, no figure numbers, all content within a 6 percent white margin.","caption":"Independent laboratory review","size":"1024x1024"}
A complete laboratory review sequence
Exam takeaway: Combine equipment, processing, and record evidence before reaching a review conclusion.
1. Confirm the work

Identify the sample, test, method, and regulated activity.

2. Check equipment evidence

Review the applicable written-program and equipment records.

3. Trace processing

Examine relevant inputs, calculations, outputs, and authorized changes.

4. Review the complete record

Assess accuracy, completeness, and compliance with established standards.

5. Resolve and document

Address discrepancies and record the supported second-person conclusion.

B Worked example

Scenario: A batch manufactured under applicable Part 211 requirements will be used in a trial that includes a fictional 67-year-old participant with diabetes and osteoarthritis. A clinical cover sheet lists sodium of 139 mmol/L. The laboratory instrument's calibration is current, and the reported assay passes. However, the calculation worksheet was modified by a user whose authorization is unclear, input/output verification is not documented, and the reviewer received only the final value.

  1. Identify the task: Decide whether the laboratory review can be completed on the evidence provided.
  2. Extract key facts: Processing authorization, verification evidence, and the complete laboratory record are unresolved. The participant's medical details do not answer those questions.
  3. Apply the rule: Equipment checks, controlled computerized processing, complete test records, and second-person review each require appropriate evidence.
  4. Eliminate alternatives: Current calibration addresses equipment status; it does not validate an undocumented worksheet modification. A passing assay does not establish completeness.
  5. Verify: Retrieve source test data, the applicable method, calculations, change records, and verification evidence; determine whether the modification was authorized; route unresolved discrepancies to the quality process.

Most appropriate next step: Do not sign the record as fully reviewed on the present evidence. Preserve the existing records and establish whether the reported result can be supported. Do not infer intentional misconduct solely from an incomplete review packet.

C Exam trap

Common wrong answer: Accept the second signature as proof that laboratory review was adequate. Why it is tempting: The expected approval field is populated. Single eliminating clue: The reviewer checked only the final acceptance limit and did not examine the supporting work.

D Checkpoint MCQ

A second reviewer has complete laboratory data but notices that a transcribed input differs from the original instrument record. The final result remains within its acceptance criteria. What is the most appropriate next step?

  1. A. Approve because the discrepancy does not change the pass or fail classification.
  2. B. Ask the analyst to overwrite the input and then approve the unchanged final result.
  3. C. Address the discrepancy through the controlled correction and assessment process before completing the review.
  4. D. Repeat the test and use the repeat result as the sole record supporting approval.

Answer: C.

  • A: An unchanged classification is reassuring, but review still requires an accurate and explainable record.
  • B: Correcting the value seems efficient, but an overwrite that removes the original entry or its history undermines controlled correction.
  • C: This preserves the evidence, supports assessment of the error, and allows a documented review conclusion based on corrected and traceable records.
  • D: A repeat may provide additional information when justified, but it does not explain or replace the original transcription discrepancy.
If you missed this: Review Equipment controls, complete records, and independent review - focus on accuracy and discrepancy resolution even when the acceptance outcome is unchanged.

1.1.1.4 4. Record-specific retention and lifecycle accountability

A Explanation

Decision conflict: Should records be deleted according to a convenient organization-wide age, or according to their applicable retention basis? Choose a record-specific assessment that preserves the complete, interpretable record and its availability.

WHY THIS IS TESTED: A retention duration without its scope and trigger can produce a confident but unsupported destruction date.

For the CGMP records addressed by the supplied blueprint, 21 CFR 211.180(a), (c), and (d) concern applicable record maintenance, retention, inspection availability, and permitted record forms. Do not infer that batch records, laboratory records, equipment records, and every other required document share the same period. Identify the governing requirement and the record's relationship to the activity before calculating a date.

The blueprint does not provide a complete record-by-record CGMP retention schedule. Consequently, this lesson does not assign a single numerical period to those categories. The operationally correct response to an unresolved period or trigger is to preserve the record and obtain an authoritative determination through the accountable role.

Retention decision checklist: Identify the record category; identify the applicable framework; establish the retention trigger and required period; preserve linked evidence needed to interpret the record; confirm continuing availability; and allow disposition only through the authorized process after applicable obligations are resolved. See Fig 5.

Accountability follows the lifecycle: The person performing work creates attributable entries, the reviewer evaluates evidence, the process or record owner defines controlled handling, and quality oversight addresses unresolved compliance concerns. Local job titles vary. Delegating storage or processing does not make the required record irrelevant to the regulated organization.

Fig 5. Retention is a documented decision, not a file-age guess
Exam takeaway: Resolve the governing period and trigger before authorizing disposition.
flowchart TD; A[Record proposed for disposition] --> B{Requirement and trigger established?}; B -->|No| C[Preserve and obtain an accountable determination]; B -->|Yes| D{Applicable retention obligations fulfilled?}; D -->|No| E[Retain with required context and availability]; D -->|Yes| F{Other applicable reasons to retain unresolved?}; F -->|Yes| C; F -->|No| G[Follow the authorized disposition process];
Preserving a linked hybrid record
Exam takeaway: Retention must preserve the relationships needed to retrieve and interpret the record.
{"prompt":"Square GxP records-management illustration. A records specialist matches an indexed paper binder with its corresponding electronic record on a workstation. Both carry the same generic fictional record identifier, and a simple index card links the paper observation, electronic data, and review record. Include a small controlled archive cabinet, no unrelated background. Clean white background, semi-flat cool blue and gray with one amber accent. Short labels Paper component, Electronic component, and Record index. Show no retention years or destruction date. No agency seals or figure numbers. Leave a 6 percent white margin.","caption":"Preserving a linked hybrid record","size":"1024x1024"}

Safety-record connection: In pharmacovigilance, preserve the connection from initial case information to documented assessment, reporting activity, and retention. Keep later information distinguishable from the initial report and maintain the relationship between source statements and subsequent decisions. This is a record-trustworthiness application, not an instruction on clinical assessment or reporting deadlines.

Safety case information across its lifecycle
Exam takeaway: Preserve source information while making assessment, reporting, and follow-up traceable.
flowchart TD; A[Initial case information] --> B[Documented intake and source record]; B --> C[Assessment with supporting rationale]; C --> D[Reporting activity and retained evidence]; B --> E[Linked follow-up information]; E --> C; D --> F[Controlled retention and retrieval];
Source information and later safety-case decisions
Exam takeaway: A later assessment must remain distinguishable from the information originally received.
{"prompt":"Square educational illustration of a safety-records team reviewing a generic incoming source report beside separate assessment, reporting, and retained-record folders. A later follow-up note is visibly attached to the same fictional case identifier without covering the original report. Use concise labels Source, Assessment, Reporting, and Retention. Portray records work only, with no diagnostic claims, reporting deadlines, drug recommendations, or patient identifiers. Clean semi-flat blue and gray palette with restrained amber accents, white background, thin outlines, no agency seals or figure numbers, 6 percent white outer margin.","caption":"Source information and later safety-case decisions","size":"1024x1024"}
A preservation and ownership sequence
Exam takeaway: Assign responsibility for both retaining a record and keeping it usable.
1. Inventory the components

Identify the required record and the context needed to interpret it.

2. Classify the obligations

Determine the activity, record category, and applicable framework.

3. Establish the trigger

Document the event and period governing retention.

4. Preserve usable access

Maintain protection, retrieval, and relevant record relationships.

5. Authorize the decision

Resolve uncertainty with the accountable role before disposition.

B Worked example

Scenario: An archive packet contains CGMP batch records, laboratory records, and a clinical site's investigational drug disposition records. One clinical case concerns a fictional 72-year-old participant with hypertension and chronic obstructive pulmonary disease; a routine potassium result is 4.1 mmol/L. A vendor proposes deleting the entire packet using the date on its study-closeout cover sheet. The records remain readable, and the clinical project has ended.

  1. Identify the task: Decide whether one cover-sheet date supports disposition of all included records.
  2. Extract key facts: The packet combines different activities and record categories. Readability, clinical demographics, and project closure do not establish each retention basis.
  3. Apply the rule: Determine the applicable framework, trigger, and period for the constituent records and preserve necessary relationships.
  4. Eliminate alternatives: Administrative closeout is not automatically the governing trigger for every record, and a vendor schedule does not replace applicable obligations.
  5. Verify: Have the accountable owners document each retention basis and confirm whether any other applicable reason to retain remains before authorizing disposition.

Most appropriate next step: Preserve the packet while the records are classified. A single operational retention period may be used if it is justified to satisfy all applicable obligations, but that conclusion must be established rather than assumed.

C Exam trap

Common wrong answer: Close an archive finding because a backup job completed successfully. Why it is tempting: Successful copying suggests the records are safe. Single eliminating clue: No one can retrieve and interpret the required record from the retained copy.

D Checkpoint MCQ

A legacy instrument will be retired. Its result reports have been saved, but the organization has not established whether those reports preserve all information required to reconstruct the tests. What is the most appropriate next step?

  1. A. Retire the system because every reported result is present.
  2. B. Retire the system after printing the reports and collecting a manager's signature.
  3. C. Preserve the necessary records and assess the proposed retained representation before decommissioning.
  4. D. Restart the retention period from the export date and then retire the system.

Answer: C.

  • A: The presence of final results suggests coverage, but the scenario leaves supporting information and reconstructability unresolved.
  • B: Paper copies and approval may support a controlled process, but they do not prove that the retained representation is complete.
  • C: This correctly preserves access while determining whether required content, context, and relationships will survive retirement.
  • D: A new export date appears administratively convenient, but it does not establish the governing retention trigger or preserve missing context.
If you missed this: Review Record-specific retention and lifecycle accountability - focus on preserving an interpretable record before removing the system that supports it.
Quick Recall:
  • Second-person laboratory review evaluates accuracy, completeness, and ______. Compliance with established standards.
  • A retention period must be paired with its ______. Applicable trigger.
  • True or false: A successful backup proves inspection-ready retrieval. False; usable retrieval must also be established.
TRAPS

Exam Traps & Differentiators

Common traps & distractors:
  • Wrong answer: Assign one framework to the whole company. Tempting because one quality system appears simpler. Eliminating clue: The scenario includes activities with different regulatory purposes.
  • Wrong answer: Treat a polished scanned packet as a verified complete record. Tempting because every page looks readable. Eliminating clue: Required contextual information is absent from the scan.
  • Wrong answer: Treat a vendor's release note as proof that a local processing change is authorized. Tempting because the vendor appears technically authoritative. Eliminating clue: Local authorization for the implemented change is not established.
  • Wrong answer: Reclassify original case information to match the final assessment. Tempting because a consistent narrative is easier to read. Eliminating clue: The original report and later interpretation describe different stages of the record.
Table 4. Looks similar but requires a different decision
Similar-looking pairDecisive distinctionPractical response
Missing from an export versus missing from the original recordThe export may omit information that the source system still preserves.Inspect the source before deciding whether evidence has been lost.
Scientific failure versus documentation deficiencyA failed result concerns the observed outcome; a documentation deficiency concerns the evidence supporting the activity.Assess both where present rather than assuming one explains the other.
Electronic copy versus verified retained representationFile creation alone does not establish preservation of required content and context.Evaluate the representation against what the regulated record must preserve.
Guidance recommendation versus local procedural requirementA local procedure may make a specific implementation mandatory internally without making it a universal legal requirement.Describe the source of the obligation accurately and address departures through the appropriate process.

Recognize the decision in the scenario

  • If the scenario says a worksheet changed after data entry, think: authorized change, preserved history, and appropriate verification.
  • If the scenario says only the final result was retained, think: determine what additional evidence is needed for reconstruction.
  • If the scenario says multiple record types share one folder, think: classify the contents before applying retention rules.
  • If the scenario says a framework is widely used, think: popularity does not establish applicability to this activity.
  • If the scenario says an unexplained discrepancy remains, think: preserve the evidence and use the established assessment or investigation process.
What is coming next: The course scope identifies emerging automation and AI risks, but supplies no specific proposed rule, adoption statistic, or future effective date. As new tools enter a workflow, evaluate how they affect attribution, source preservation, review, and reconstruction. Verify any claimed regulatory change against its formal status before changing a control.
Review connection: Return to Binding requirements versus reference guidance whenever a proposed control rests on a rule whose applicability has not been established.
ALGO

Algorithm / Approach

Use this five-step approach when a record is presented for a regulated decision. The point of escalation is an unresolved evidence or applicability question, not merely an unfamiliar file format. See Fig 6.

1. Scope the activity

Identify the regulated work, record purpose, framework, and accountable role.

2. Assemble the evidence

Locate source data, relevant metadata, changes, and linked paper or electronic components.

3. Evaluate controls

Check appropriate equipment, authorization, verification, and required review evidence.

4. Address gaps

Preserve existing evidence, document uncertainty, and use the authorized correction or investigation process.

5. Preserve the outcome

Document the supported decision and maintain the record under its applicable retention and availability requirements.

Fig 6. A practical decision gate for regulated records
Exam takeaway: Resolve applicability and evidence gaps before relying on a record for its intended decision.
flowchart TD; A[Record presented for a regulated decision] --> B{Scope and required record established?}; B -->|No| C[Clarify with the accountable owner]; B -->|Yes| D{Evidence and required review support the decision?}; D -->|No| E[Preserve evidence and address the gap]; D -->|Yes| F[Document the supported conclusion]; F --> G[Maintain required retention and availability]; C --> H[Reassess after clarification]; E --> H;

Key points

  • Begin with the activity and record purpose before choosing a regulatory framework.
  • Evaluate the supporting evidence as well as the final result.
  • Keep equipment controls, complete records, and independent review distinct but connected.
  • Base preservation and disposition on documented obligations and usable retrieval.
QUIZ

Self-check quiz

Question 1

A protected database contains values that meet the stated acceptance criteria. After a migration, it no longer identifies which operator entered each original observation. Which conclusion is most appropriate?

  1. A. Information security establishes integrity because unauthorized access is prevented.
  2. B. Acceptable values establish integrity because the intended decisions remain unchanged.
  3. C. Integrity remains unresolved because attribution of the original observations is missing.
  4. D. A current supervisor's approval can serve as attribution for all historical entries.

Question 2

A team is designing controls for FDA-regulated records while consulting international guidance. Select TWO statements that are supported.

  1. A. Identify the applicable underlying recordkeeping requirements before deciding how electronic controls apply.
  2. B. Apply Part 11 to every file in the application because the application also contains regulated records.
  3. C. Distinguish applicable legal obligations from reference guidance and from local implementation choices.
  4. D. Treat an international reference framework as a replacement for an applicable FDA recordkeeping requirement when its controls are more detailed.

Question 3

A finished-pharmaceutical laboratory has current equipment calibration records. Its computerized processing permits changes to master control records without established authorization, and the appropriate verification of inputs and outputs is not demonstrated. Which response best addresses the supplied scope?

  1. A. Accept the controls because calibration establishes the reliability of the computerized results.
  2. B. Address authorized-change controls and appropriate input/output verification in addition to equipment checks.
  3. C. Add a second signature to the calibration log to cover the processing controls.
  4. D. Retain the final outputs for longer so that the processing-control uncertainty can be reviewed later.

Question 4

A second laboratory reviewer receives a passing result, an analyst signature, and a method identifier. The underlying test data and calculations are unavailable in the review packet. What is the most appropriate next step?

  1. A. Complete the review because the analyst has already accepted responsibility for the result.
  2. B. Complete the review after checking that the method identifier matches the procedure list.
  3. C. Obtain the supporting record and evaluate accuracy, completeness, and compliance before documenting completion.
  4. D. Request a repeat test and use the new passing result in place of the incomplete original record.

Question 5

A records team receives batch records, laboratory records, and investigator records in one archive. It has no documented determination of their governing retention triggers. Which approach is most appropriate?

  1. A. Use the creation date of the newest document as the common trigger for the archive.
  2. B. Apply the batch-related retention basis to every record because the archive contains batch records.
  3. C. Use the storage vendor's standard deletion schedule because the vendor maintains the archive.
  4. D. Preserve the records while the responsible owners establish the applicable requirements, categories, triggers, and periods.
ANSWERS

Answer key & explanations

Question 1: C

  • A: Access protection is valuable and therefore tempting, but it does not restore the identity of the person who made an original entry.
  • B: Stable acceptance decisions suggest useful data, but the plausibility of the values does not establish the missing history.
  • C: Correct; the unavailable operator information leaves an attribution gap that must be assessed and addressed.
  • D: Current approval may document a present review, but it cannot truthfully substitute for the identity of the historical originator.
If you missed this: Review Trustworthiness versus a plausible result - focus on why protection and plausibility do not replace attribution.

Question 2: A and C

  • A: Correct; establishing the underlying record obligation gives the electronic-control assessment its proper scope.
  • B: Uniform treatment appears administratively simple, but software co-location does not make all files subject to the same regulatory requirements.
  • C: Correct; distinguishing authority and implementation prevents both underapplying requirements and overstating reference recommendations.
  • D: A detailed reference may improve control design, but detail does not authorize replacing an applicable underlying FDA obligation.
If you missed this: Review Binding requirements versus reference guidance - focus on applicability and the source of each obligation.

Question 3: B

  • A: Current calibration supports confidence in equipment performance, but it does not establish that master-record changes or computerized processing are controlled.
  • B: Correct; the supplied equipment and computer-control framework includes authorization and appropriate input/output verification in addition to equipment checks.
  • C: A second signature may appear to add oversight, but signing an equipment log does not implement missing authorization or verification controls.
  • D: Longer preservation may support later examination, but it does not correct the present weakness in how records are changed and processed.
If you missed this: Review Equipment controls, complete records, and independent review - focus on the separate evidence needed for equipment status and computerized data handling.

Question 4: C

  • A: Analyst identification supports attribution, but it does not replace the second person's required evaluation of the supporting work.
  • B: A matching method identifier is relevant, but it cannot establish how the test was performed or whether its calculations are accurate.
  • C: Correct; obtaining the underlying record enables the reviewer to assess the required dimensions and determine whether any gap remains.
  • D: A repeat test can seem to provide a clean solution, but it does not reconstruct or resolve the incomplete record of the original activity.
If you missed this: Review Equipment controls, complete records, and independent review - focus on evidence-based second-person review rather than final-result confirmation.

Question 5: D

  • A: The newest date is easy to identify, but convenience does not establish a legally or procedurally applicable retention trigger.
  • B: Batch records are central to manufacturing, but their retention basis cannot automatically be extended to every other activity represented in a mixed archive.
  • C: A vendor schedule may organize storage, but outsourced custody does not determine or eliminate the regulated record's applicable obligations.
  • D: Correct; preservation prevents premature loss while accountable owners establish the record-specific basis for retention and eventual disposition.
If you missed this: Review Record-specific retention and lifecycle accountability - focus on classifying records and establishing triggers before calculating disposition dates.
RAPID

Rapid review / cheat-sheet

  • Record relocation → Verify that the move preserves usable retrieval, not merely file presence.
  • Imported value → Trace the relationship between the source and the receiving record.
  • Delegated storage → Keep the accountable record owner identifiable.
  • Mixed archive → Classify the contents before relying on the folder's title.
  • Format conversion → Compare preserved meaning and context, not visual resemblance alone.
  • Evidence gap → Describe what is unknown before attributing intent.
  • Regulatory forecast → Distinguish a proposal or trend from an effective obligation.
  • Scope boundary → Record why a framework was included or excluded.

See also: Regulatory Requirements Across Clinical and Nonclinical Studies develops the neighboring clinical and nonclinical scope distinctions. GxP Data Flows and Record Preservation extends the lifecycle and reconstruction concepts introduced here.

Blueprint anchor recap: GxP foundations and regulatory scope; GxP requirements and regulatory responsibilities; objective bp.d1.t1; subject: regulatory frameworks. This lesson covers trustworthy records, applicability, the supplied CGMP equipment and record requirements, independent laboratory review, and record-specific preservation.

References / further study: The following authoritative instruments are named in the supplied course blueprint. Coverage follows its November 1, 2026 scope snapshot; no additional publication edition or regulatory update is asserted.

  1. United States. Food and Drug Administration. "Current Good Manufacturing Practice for Finished Pharmaceuticals." Code of Federal Regulations, title 21, part 211, secs. 211.68, 211.180, 211.188, 211.192, and 211.194.
  2. United States. Food and Drug Administration. "Electronic Records; Electronic Signatures." Code of Federal Regulations, title 21, part 11.
  3. United States. Food and Drug Administration. "Investigator Recordkeeping and Record Retention." Code of Federal Regulations, title 21, sec. 312.62.
End of your free lesson

Keep going with the full GxP Data Integrity Professional Certificate

You just studied the way members do, in the same lesson interface. Full access unlocks every lesson, the question bank and flashcards for a full year.

Up next with full access1.1.2 - Regulatory Requirements Across Clinical and Nonclinical Studies

One payment per program